0

Poly(ethylene Glycol) Methacrylate Hydrolyzable Microspheres for Transient Vascular Embolization

Stéphanie Louguet, Valentin Verret, Laurent Bédouet, Emeline Servais, Florentina Pascale, Michel Wassef, Denis Labarre, Alexandre Laurent, Laurence Moine

Acta Biomater. 2014 Mar;10(3):1194-205.

PMID: 24321348

Abstract:

Poly(ethylene glycol) methacrylate (PEGMA) hydrolyzable microspheres intended for biomedical applications were readily prepared from poly(lactide-co-glycolide) (PLGA)-poly(ethylene glycol) (PEG)-PLGA crosslinker and PEGMA as a monomer using a suspension polymerization process. Additional co-monomers, methacrylic acid and 2-methylene-1,3-dioxepane (MDO), were incorporated into the initial formulation to improve the properties of the microspheres. All synthesized microspheres were spherical in shape, calibrated in the 300-500 μm range, swelled in phosphate-buffered saline (PBS) and easily injectable through a microcatheter. Hydrolytic degradation experiments performed in PBS at 37 °C showed that all of the formulations tested were totally degraded in less than 2 days. The resulting degradation products were a mixture of low-molecular-weight compounds (PEG, lactic and glycolic acids) and water-soluble polymethacrylate chains having molecular weights below the threshold for renal filtration of 50 kg mol(-1) for the microspheres containing MDO. Both the microspheres and the degradation products were determined to exhibit minimal cytotoxicity against L929 fibroblasts. Additionally, in vivo implantation in a subcutaneous rabbit model supported the in vitro results of a rapid degradation rate of microspheres and provided only a mild and transient inflammatory reaction comparable to that of the control group.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP25736861 Poly(ethylene glycol) methacrylate Poly(ethylene glycol) methacrylate 25736-86-1 Price
qrcode